Assignee
TAIZHOU EOC PHARMA CO LTD
CN·1 granted patent·2 pending applications·0 citations·filing 2019–2022
Top patents by PatentIndex Score
3 records- 0151US10954246B2Compound of EOC315 Mod.I crystal form and preparation method thereofTAIZHOU EOC PHARMA CO LTD·Filed 2019·Granted Mar 23, 2021·0 cites·16 claims
- 0251US2024352016A1A cyclin-dependent kinase inhibitorTAIZHOU EOC PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 0347US2021171536A1Compound of eoc315 mod.i crystal form and preparation method thereofTAIZHOU EOC PHARMA CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TAIZHOU EOC PHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →